Psychiatric Annals 1996: Vol 26 Index

7 Pages·1996·2.5 MB·English

1996 Index, Volume 26
TOPICS 26(7):S430-S434.
January—Men’s Issues in Treatment (Kupers) Brady KT, Malcolm R, Ballenger JC;
February—Treatment of Schizophrenia (Sharma & Anticonvulsants in Substance Use Disorders;
Janicak) 26(7):S488-S491.
March—Psychiatry in Sexual Harassment (Simon & Brown WA; Effectiveness Is Not Enough: ECT and
Malmquist) Psychostimulants (Special Commentary);
April—Pharmacotherapy Algorithms for Anxiety 26(6):365-366.
Disorders (Stein & Jobson) Brown WA; PMS: A Quiet Breakthrough; 26(9):569-
May—Management of Alzheimer’s Disease (Kumar) 570.
June—Longitudinal Course of Affective Disorders Brown WA, See Yonkers KA.
(Hirschfeld) Cantillon M, See Kumar V.
July—Clozapine: Prediction of Response Casper RC; Appetite and Nutrition With Aging
(Adityanjee) (ASCP Speaks Out); 26(2):56-65.
August—Major Advances in the Treatment of Coffey CE; Brain Morphology in Primary Mood
Schizophrenia (Herz) Disorders: Implications for Electroconvulsive
September—Premenstrual Syndrome (Brown) Therapy; 26(11):713-716.
October—Bipolar Disorder (Janicak & Sharma) Coffey CE, See Duffy JD.
November—Update on Electroconvulsive Therapy Cohler BJ, Beeler JA; Schizophrenia and the Life
(Swartz) Course: Implications for Family Relations and
December—Caregiving for Psychiatric Patients Caregiving; 26(12):745-756.
(Jeste) Cohler JJ, See Cook JA.
Cook JA, Pickett SA, Razzano L, Fitzgibbon G,
AUTHORS Jonikas JA, Cohler JJ; Rehabilitation Services for
Abrams R; ECT Stimulus Parameters as Determinants Persons With Schizophrenia; 26(2):97-104.
of Seizure Quality; 26(11):701-704. Coplan JD, Pine DS, Papp LA, Gorman JM;
Adityanjee, Jampala VC; Polymorphic Variation at Algorithm-Oriented Treatment Approach for Panic
Neurotransmitter Receptor Loci and Clinical Disorder, An; 26(4):192-201.
Response; 26(7):400-405. Davis JM, Janicak PG; Risperidone: A New, Novel
Adityanjee, Pandurangi AK, Lindenmayer JP, (and Better?) Antipsychotic; 26(2):78-87.
Jampala VC; M-CPP Challenge Test as Predictor DeBattista C, See Schatzberg AF.
of Response to Clozapine in Schizophrenia; DeGoiia S, See Schatzberg AF.
26(7):395-399. Dieperink ME, Sands JR; Bipolar Mania With
Apergi F-S, See Lindenmayer J-P. Psychotic Features: Diagnosis and Treatment;
Ashford JW, Schmitt FA, Kumar V; Diagnosis of 26(10):633-637.
Alzheimer’s Disease; 26(5):262-268. Duffy JD, Coffey CE; Depression in Alzheimer’s
Baker J, See Beck JC. Disease; 26(5):269-273.
Ballenger JC, See Brady KT. Eisdorfer C; Families in Distress: Caring Is More
Beck JC, White KA, Glick RL, Baker J; Who Will Than Loving; 26(5):285-288.
Be Hospitalized After Emergency Evaluation? Ereshefsky L; Drug Interactions of Antidepressants;
(Contemporary Psychiatry); 26(8):544-546. 26(6):342-350.
Beeler JA, See Cohler BJ. Evans CM, See Swartz CM.
Bell CC; Treatment Issues for African-American Men; Fawcett J; Algorithms—The Scaffolding for
26(1):33-36. Applying What is Known (Editorial); 26(4):189.
Benedek EP, Voigt CJ, Heisel DE; Brief Personal Fawcett J; Bipolar Disorder: More on Diagnosis and
Reflections on Sexual Harassment; 26(3):128-131. Treatment (Editorial); 26(10):632.
Bennett JA, See Keck PE Jr. Fawcett J; Bipolar II Disorder; 26(7):S440-S443.
Bergman SJ; Male Relational Dread; 26(1):24-28. Faweett J; CaregiviAn Qgu:ie t Crisis (Editorial);
Bergsholm P, Swartz CM; Anesthesia in 26(12):744.
Electroconvulsive Therapy and Alternatives to Fawcett J; Caring Can Be a Lot More Than Loving
Barbiturates; 26(11):709-712. (Editorial); 26(5):261.
Bloch M, See Roca CA. Fawcett J; Feast of New Perspectives on the Bipolar
Bowden CL, Rhodes LJ; Mania in Children and Spectrum and Anticonvulsants in Other CNS
Adolescents: Recognition and Treatment; Disorders, A (Editorial); 26(7):S429.
Psychiatric Annals 26:12/December 1996
Faweett J; From Childhood On—Depressive Jampala VC, See Adityanjee.
Disorders Should Be Recognized and Treated Jampala VC, See Adityanjee.
(Editorial); 26(6):312. Janicak PG, See Davis JM.
Fawcett J; New Considerations in the Treatment of the Janicak PG, See Kopacz DR.
Psychoses (Editorial); 26(2):67. Janicak PG, Sadek HS; Psychopharmacotherapy for
Fawcett J; Psychiatry: A Delight and a Chalienge Acute and Recurrent Psychotic Disorders;
(Editorial); 26(1):20. 26(2):68-77.
Fawcett J; Schizophrenia—A New Ball Game? Jefferson JW, Greist JH; Pharmacotherapy of
(Editorial); 26(7):384. Obsessive-Compulsive Disorder, The; 26(4):202-
Fawcett J; Sexual Harassment and Psychiatry 209.
(Editorial); 26(3):126-127. Jeste DV, See Patterson TL.
Fawcett J; We Need More Procedures—To Get More Jobson KO, See Stein DJ.
Respect (Editorial); 26(11):700. Jonikas JA, See Cook JA.
Fawcett J; Which Comes First? (Editorial); 26(9):568. Kasckow JW, See McElroy SL.
Fawcett J; Will Advances in the Treatment of Keck PE Jr, See McElroy SL.
Schizophrenia Reach the Patient? (Editorial); Keck PE Jr, McElroy SL, Stanton SP, Bennett JA;
26(8):513. Pharmacoeconomic Aspects of the Treatment of
Fitzgibbon G, See Cook JA. Bipolar Disorder; 26(7):S449-S453.
Frances RJ; Schizophrenia and Substance Abuse; Kimura M, Meyer JM, Simpson GM;
26(8):523-527. Anticholinergic Prophylaxis Revisited (ASCP
Gebre-Medhin P, See Tohen M. Speaks Out); 26(9):602-603.
Glick ID, Lecrubier Y, Montgomery SA, Vinar O, Klein DF; Comments on “Integrity and Misconduct in
Klein DF; Efficacious and Safe Psychotropics Noi Research” (ASCP Speaks Out); 26(10):669-675.
Available in the United States (ASCP Speaks Out); Klein DF, See Glick ID.
26(6):354-361. Kopacz DR, Janicak PG; Relationship Between
Glick RL, See Beck JC. Bipolar Disorder and Personality, The; 26(10):644-
Goldberg JF, Harrow M, Sands JR; Lithium and the 650.
Longitudinal Course of Bipolar Illness; Kovacs M; Course of Childhood-Onset Depressive
26(10):651-658. Disorders, The; 26(6):326-330.
Goldman HH; Using Cost-Effectiveness Data in Kruesi MJP, See Noronha SF.
Benefit Design; 26(8):528-530. Kumar V, See Ashford JW.
Goldman MB; Update on Treatment and Kumar V, Cantillon M; Update on the Development
Pathophysiology of Water Imbalance in of Medication for Memory and Cognition in
Schizophrenia; 26(2):93-96. Alzheimer’s Disease; 26(5):280-284.
Gorman JM, See Coplan JD. Kupers TA; Men’s Issues in Treatment; 26(1):22-23.
Grant I, See Patterson TL. Kupers TA; Men at Work and Out of Work; 26(1):29-
Greist JH, See Jefferson JW. on.
Grossberg GT, See Lake JT. Kwon J, See Hollander E.
Grossman R, See Hollander E. Lake JT, Grossberg GT; Management of Psychosis,
Halbreich U; Reflections on the Cause of Agitation, and Other Behavioral Problems in
Premenstrual Syndrome; 26(9):581-585. Alzheimer’s Disease; 26(5):274-279.
Harrington RC; Adult Outcomes of Childhood and Lawson JS; Gender Issues in Electroconvulsive
Adolescent Depression: Influences on the Risk for Therapy; 26(11):717-720.
Adult Depression; 26(6):320-325. Lebowitz BD, Light E; Aging Caregivers of
Harrow M, See Goldberg JF. Psychiatric Patients: Healthcare Perspectives, The;
Heisel DE, See Benedek EP. 26(12):785-791.
Heit S, Nemeroff CB; Migraine and Affective Lecrubier Y, See Glick ID.
Disorders; 26(7):S460-S463. Lenhart SA, Shrier DK; Potential Costs and Benefits
Herz MI; Introduction (Major Advances in the of Sexual Harassment Litigation; 26(3):132-138.
Treatment of Schizophrenia); 26(8):514. Lieberman JA; Pharmacotherapy for Patients with
Herz MI; Psychosocial Treatment; 26(8):531-535. First-Episode, Acute, and Refractory
Herz MI; Panel Discussion; 26(8):536-538. Schizophrenia; 26(8):515-518.
Hirschfeld RMA; Long-Term Nature of Depression, Liebowitz MR, See Marshall RD.
The; 26(6):313-314. Light E, See Lebowitz BD.
Hirschfeld RMA; Schizoaffective Disorder and Lindenmayer J-P, Apergi F-S; Relationship Between
Psychotic Mania; 26(7):S435-S439. Clozapine Plasma Levels and Clinical Response,
Hollander E, Grossman R, Stein DJ, Kwon J; The; 26(7):406-412.
Borderline Personality Disorder and Impulsive- Lindenmayer JP, See Adityanjee.
Aggression: The Role for Divalproex Sodium
(continued on page 802)
Treatment; 26(7):S464-S469.
Psychiatric Annals 26:12/December 1996
(continued from page 800) $459.
Lott AD, See McElroy SL. Sadek HS, See Janicak PG.
Maier W; Onset and Course of Affective Disorders in Sands JR, See Dieperink ME.
Subjects at Risk: A Prospective Family Study: Sands JR, See Goldberg JF.
26(6):315-319. Schatzberg AF; Course of Depression in Adults:
Malcolm R, See Brady KT. Treatment Options; 26(6):336-341.
Malhotra AK, Pickar D; Biologic Predictors of Schatzberg AF, DeBattista C, DeGolia S; Valproate in
Clozapine Response in Schizophrenia; 26(7):390- the Treatment of Agitation Associated With
394. Depression; 26(7):S470-S473.
Malmquist CP; Use and Misuse of Psychiatry in Schmidt PJ, See Roca CA.
Schmitt FA, See Ashford JW.
Sexual Harassmcat Cases, The; 26(3):149-156.
Marshall RD, Schneier FR; Algorithm for the Schneier FR, See Marshall RD.
Pharmacotherapy of Social Phobia, An; 26(4):210- Schooler NR; Advances in Maintenance Treatment:
216. 26(8):519-522.
Marshall RD, Stein DJ, Liebowitz MR, Yehuda R; Semple SJ, See Patterson TL.
Pharmacotherapy Algorithm in the Treatment of Shapiro LE, See Sharma RP.
Posttraumatic Stress Disorder, A; 26(4):217-226. Sharma R, See Owley T.
McElroy SL, See Keck PE Jr. Sharma RP, Shapiro LE; SHT,, Receptor System:
McElroy SL, Kasckow JW, Lott AD, Keck PE Jr; Possible Implications for Schizophrenic Negative
Valproate in the Treatment of Behavioral Agitation Symptomatology, The; 26(2):88-92.
of Dementia; 26(7):S474-S479. Shaw WS, See Patterson TL.
Meltzer HY; Predictors of Response to Clozapine; Shrier DK, See Lenhart SA.
26(7):385-389. Simon J; Getting Older; 26(1):41-44.
Meyer JM, See Kimura M. Simon RI; Credible Forensic Psychiatric Evaluation in
Montgomery SA, See Glick ID. Sexual Harassment Litigation, The; 26(3):139-148.
Nelson JC; Importance of Intent-to-Treat Response Simpson GM, See Kimura M.
Rates for the Clinician (ASCP Speaks Out); 26(1):8- Simpson GM, Pi EH; What’s Happening to the
18. Neuroleptic Malignant Syndrome? (ASCP Speaks
Nemeroff CB, See Heit S. Out); 26(4):172-174.
Noronha SF, Kruesi MJP; Bipolar Disorder in the Stahl SM; Beyond the Second Messenger: How
Young: Issues in Diagnosis and Treatment; Molecular Events Mediate Receptor
26(10):638-643. Downregulation (Psychopharm Psnapshots);
Owley T, Sharma R; Drug-Induced Mania: A Critical 26(6):302-303.
Review; 26(10):659-664. Stahl SM; Immediate Actions of SSRIs (Psychopharm
Pandurangi AK, See Adityanjee. Psnapshots); 26(9):564-565.
Papp LA, See Coplan JD. Stahl SM; Long-Term Actions of SSRIs (Psychopharm
Patrick JH, Pruchno RA; Mothers’ Perceptions of Psnapshots); 26(10):626-628.
Service Use and Unmet Service Needs for Their Stahl SM; New Antidepressants Act By Four Distinct
Adult Offspring With Chronic Mental Illness; Mechanisms, The (Psychopharm Psnapshots);
26(12):757-765. 26(7):377-382.
Patterson TL, Semple SJ, Shaw WS, Grant I, Jeste Stahl SM; Second Messenger Systems (Psychopharm
DV; Researching the Caregiver: Family Members Psnapshots); 26(4):183-184.
Who Care for Older Psychotic Patients; 26(12):772- Stahl SM; Serotonin Receptors (Psychopharm
784. Psnapshots); 26(8):505-507.
Pearlstein T; Nonpharmacologic Treatment of Stahl SM; Serotonin Pathways: Mediators of SSRI Side
Premenstrual Syndrome; 26(9):590-594. Effects; 26(12):738-742.
Pi EH, See Simpson GM. Stahl SM; Serotonin Pathways: Mediators of SSRI
Pickar D, See Malhotra AK. Therapeutic Actions (Psychopharm Psnapshots);
Pickett SA, See Cook JA. 26(11):695-696.
Pike S, See Tohen M. Stahl SM; Two Receptor Superfamilies Mediate Fast
Pine DS, See Coplan JD. and Siow Neurotransmission (Psychopharm
Pruchno RA, See Patrick JH. Psnapshots); 26(5):244-253.
Razzano L, See Cook JA. Stanton SP, See Keck PE Jr.
Rhodes LJ, See Bowden CL. Stein DJ, See Hollander E.
Roca CA, Schmidt PJ, Bloch M, Rubinow DR; Stein DJ, See Marshall RD.
Implications of Endocrine Studies of Premenstrual Stein DJ, Jobson KO; Psychopharmacology
Syndrome; 26(9):576-580. Algorithms: Pros and Cons; 26(4):190-191.
Rubinow DR, See Roca CA. Stein TS; Homosexuality and Homophobia in Men;
Sachs G; Is Divalproex Sodium an Appropriate Initial 26(1):37-40.
Treatment for Bipolar Depression?; 26(7):S454- Steiner M, Wilkins A; Diagnosis and Assessment of
Psychiatric Annals 26:12/December 1996

Premenstrual Dysphoria; 26(9):571-575. Out); Casper RC; 26(2):56-65.
Swartz CM; Summary of Methods to Potentiate ECT Beyond Bitemporal and Right Unilateral Electrode
Seizure, A; 26(11):721. Placements; Swartz CM, Evans CM; 26(11):705-
Swartz CM, See Bergsholm P. 708.
Swartz CM, Evans CM; Beyond Bitemporal and Right Beyond the Second Messenger: How Molecular
Unilateral Electrode Placements; 26(11):705-708. Events Mediate Receptor Downregulation
Thompson PM; Generalized Anxiety Disorder (Psychopharm Psnapshots); Stahl SM; 26(6):302-
Treatment Algorithm; 26(4):227-232. 303.
Tohen M, Zarate CA Jr, Zarate SB, Gebre-Medhin P, Biologic Predictors of Clozapine Response in
Pike S; McLean/Harvard First-Episode Mania Schizophrenia; Malhotra AK, Pickar D; 26(7):390-
Project: Pharmacologic Treatment and Outcome, 394.
The; 26(7):S444-S448. Bipolar Disorder in the Young: Issues in Diagnosis
Vaddadi K; Stress of Caregiving for the Chronically and Treatment; Noronha SF, Kruesi MJP:
Mentally Ill; 26(12):766-771. 26(10):638-643.
Vinar O, See Glick ID. Bipolar Disorder: More on Diagnosis and Treatment
Voigt CJ, See Benedek EP. (Editorial); Fawcett J; 26(10):632.
Weissman MM, See Wolk SI. Bipolar II Disorder; Fawcett J; 26(7):S440-S443.
White KA, See Beck JC. Bipolar Mania With Psychotic Features: Diagnosis
Wilkins A, See Steiner M. and Treatment; Dieperink ME, Sands JR;
Wolk SI, Weissman MM; Suicidal Behavior in 26(10):633-637.
Depressed Children Grown Up: Preliminary Results Borderline Personality Disorder and Impulsive-
of a Longitudinal Study; 26(6):331-335. Aggression: The Role for Divalproex Sodium
Yehuda R, See Marshall RD. Treatment; Hollander E, Grossman R, Stein DJ,
Yonkers KA, Brown WA; Pharmacologic Treatments Kwon J; 26(7):S464-S469.
for Premenstrual Dysphoric Disorder; 26(9):586- Brain Morphology in Primary Mood Disorders:
589. Implications for Electroconvulsive Therapy;
Zajecka J; Panic Disorder and Posttraumatic Stress Coffey CE; 26(11):713-716.
Disorder; 26(7):S480-S487. Brief Personal Reflections on Sexual Harassment;
Zarate CA Jr, See Tohen M. Benedek EP, Voigt CJ, Heisel DE; 26(3):128-131.
Zarate SB, See Tohen M. Caregiving: A Quiet Crisis (Editorial); Fawcett J;
26(12):744.
TITLES Caring Can Be a Lot More Than Loving (Editorial);
SHT,, Receptor System: Possible Implications for Fawcett J; 26(5):261.
Schizophrenic Negative Symptomatology, The; Comments on “Integrity and Misconduct in
Sharma RP, Shapiro LE; 26(2):88-92. Research” (ASCP Speaks Out); Klein DF;
Adult Outcomes of Childhood and Adolescent 26(10):669-672.
Depression: Influences on the Risk for Adult Course of Childhood-Onset Depressive Disorders,
Depression; Harrington RC; 26(6):320-325. The; Kovacs M; 26(6):326-330.
Advances in Maintenance Treatment; Schooler NR; Course of Depression in Adults: Treatment Options;
26(8):519-522. Schatzberg AF; 26(6):336-341.
Aging Caregivers of Psychiatric Patients: Credible Forensic bsychiatric Evaluation in Sexual
Healthcare Perspectives, The; Lebowitz BD, Light Harassment Litigation, The; Simon RI; 26(3):139-
E; 26(12):785-791. 148.
Algorithm for the Pharmacotherapy of Social Depression in Alzheimer’s Disease; Duffy JD, Coffey
Phobia, An; Marshall RD, Schneier FR; 26(4):210- CE; 26(5):269-273.
216. Diagnosis and Assessment of Premenstrual
Algorithm-Oriented Treatment Approach for Panic Dysphoria; Steiner M, Wilkins A; 26(9):571-575.
Disorder, An; Coplan JD, Pine DS, Papp LA, Diagnosis of Alzheimer’s Disease; Ashford JW,
Gorman JM; 26(4):192-201. Schmitt FA, Kumar V; 26(5):262-268.
Algorithms—The Scaffolding for Applying What is Drug Interactions of Antidepressants; Ereshefsky L;
Known (Editorial); Fawcett J; 26(4):189. 26(6):342-350.
Anesthesia in Electroconvulsive Therapy and Drug-Induced Mania: A Critical Review; Owley T,
Alternatives to Barbiturates; Bergsholm P, Swartz Sharma R; 26(10):659-664.
CM; 26(11):709-712. ECT Stimulus Parameters as Determinants of
Anticholinergic Prophylaxis Revisited (ASCP Seizure Quality; Abrams R; 26(11):701-704.
Speaks Out); Kimura M, Meyer JM, Simpson GM; Effectiveness Is Not Enough: ECT and
26(9):602-603. Psychostimulants (Special Commentary); Brown
Anticonvulsants in Substance Use Disorders; Brady WA; 26(6):365-366.
Efficacious and Safe Psychotropics Not Available in
KT, Malcolm R, Ballenger JC; 26(7):S488-S491.
Appetite and Nutrition With Aging (ASCP Speaks the United States (ASCP Speaks Out); Glick ID,
Psychiatric Annals 26:12/December 1996
Lecrubier Y, Montgomery SA, Vinar O, Klein DF; 26(12):757-765.
26(6):354-361. New Antidepressants Act By Four Distinct
Families in Distress: Caring Is More Than Loving; Mechanisms, The (Psychopharm Psnapshots);
Eisdorfer C; 26(5):285-288. Stahl SM; 26(7):377-382.
Feast of New Perspectives on the Bipolar Spectrum New Considerations in the Treatment of the
and Anticonvulsants in Other CNS Disorders, A Psychoses (Editorial); Fawcett J; 26(2):67.
(Editorial); Fawcett J; 26(7):S429. Nonpharmacologic Treatment of Premenstrual
From Childhood On—Depressive Disorders Should Syndrome; Pearlstein T; 26(9):590-594.
Be Recognized and Treated (Editorial); Fawcett J; Onset and Course of Affective Disorders in Subjects
26(6):312. at Risk: A Prospective Family Study; Maier W;
Gender Issues in Electroconvulsive Therapy; 26(6):315-319.
Lawson JS; 26(11):717-720. PMS: A Quiet Breakthrough; Brown WA; 26(9):569-
Generalized Anxiety Disorder Treatment Algorithm; 570.
Thompson PM; 26(4):227-232. Panel Discussion; 26(8):536-538.
Getting Older; Simon J; 26(1):41-44. Panic Disorder and Posttraumatic Stress Disorder;
Homosexuality and Homophobia in Men; Stein TS; Zajecka J; 26(7):S480-S487.
26(1):37-40. Pharmacoeconomic Aspects of the Treatment of
Immediate Actions of SSRIs (Psychopharm Bipolar Disorder; Keck PE Jr, McElroy SL,
Psnapshots); Stahl SM; 26(9):564-565. Stanton SP, Bennett JA; 26(7):S449-S453.
Implications of Endocrine Studies of Premenstrual Pharmacologic Treatments for Premenstrual
Syndrome; Roca CA, Schmidt PJ, Bloch M, Dysphoric Disorder; Yonkers KA, Brown WA;
Rubinow DR; 26(9):576-580. 26(9):586-589.
Importance of Intent-to-Treat Response Rates for Pharmacotherapy Algorithm in the Treatment of
the Clinician (ASCP Speaks Out); Nelson JC; Posttraumatic Stress Disorder, A; Marshall RD,
26(1):8-18. Stein DJ, Liebowitz MR, Yehuda R; 26(4):217-226.
Introduction (Major Advances in the Treatment of Pharmacotherapy for Patients with First-Episode,
Schizophrenia); Herz MI; 26(8):514. -Acute, and Refractory Schizophrenia; Lieberman
Is Divalproex Sodium an Appropriate Initial JA; 26(8):515-518.
Treatment for Bipolar Depression?; Sachs G; Pharmacotherapy of §Obsessive-Compulsive
26(7):S454-S459. Disorder, The; Jefferson JW, Greist JH; 26(4):202-
Lithium and the Longitudinal Course of Bipolar 209.
Iiiness; Goldberg JF, Harrow M, Sands JR; Polymorphic Variation at Neurotransmitter
26(10):651-658. Receptor Loci and Clinical Response; Adityanjee,
Long-Term Actions of SSRIs (Psychopharm Jampala VC; 26(7):400-405.
Psnapshots); Stahl SM; 26(10):626-628. Potential Costs and Benefits of Sexual Harassment
Long-Term Nature of Depression, The; Hirschfeld Litigation; Lenhart SA, Shrier DK; 26(3):132-138.
RMA; 26(6):313-314. Predictors of Response to Clozapine; Meltzer HY;
M-CPP Challenge Test as Predictor of Response to 26(7):385-389.
Clozapine in Schizophrenia; Adityanjee, Psychiatry: A Delight and a Challenge (Editorial);
Pandurangi AK, Lindenmayer JP, Jampala VC; Fawcett J; 26(1):20.
26(7):395-399. Psychopharmacology Algorithms: Pros and Cons;
Male Relational Dread; Bergman SJ; 26(1):24-28. Stein DJ, Jobson KO; 26(4):190-191.
Management of Psychosis, Agitation, and Other Psychopharmacotherapy for Acute and Recurrent
Behavioral Problems in Alzheimer’s Disease; Psychotic Disorders; Janicak PG, Sadek HS;
Lake JT, Grossberg GT; 26(5):274-279. 26(2):68-77.
Mania in Children and Adolescents: Recognition Psychosocial Treatment; Herz MI; 26(8):531-535.
and Treatment; Bowden CL, Rhodes LJ; Reflections on the Cause of Premenstrual
26(7):S430-S434. Syndrome; Halbreich U; 26(9):581-585.
McLean/Harvard First-Episode Mania Project: Rehabilitation Services for Persons With
Pharmacologic Treatment and Outcome, The; Schizophrenia; Cook JA, Pickett SA, Razzano L,
Tohen M, Zarate CA Jr, Zarate SB, Gebre-Medhin P, Fitzgibbon G, Jonikas JA, Cohler JJ; 26(2):97-104.
Pike S; 26(7):S444-S448. Relationship Between Bipolar Disorder and
Men at Work and Out of Work; Kupers TA; 26(1):29- Personality, The; Kopacz DR, Janicak PG;
32. 26(10):644-650.
Men’s Issues in Treatment; Kupers TA; 26(1):22-23. Relationship Between Clozapine Plasma Levels and
Migraine and Affective Disorders; Heit S, Nemeroff Clinical Response, The; Lindenmayer J-P, Apergi
CB; 26(7):S460-S463. F-S; 26(7):406-412.
Mothers’ Perceptions of Service Use and Unmet Researching the Caregiver: Family Members Who
Service Needs for Their Adult Offspring With Care for Older Psychotic Patients; Patterson TL,
Chronic Mental Illness; Patrick JH, Pruchno RA;
(continued on page 806)
Psychiatric Annals 26:12/December 1996
(continued from page 804) Treatment Issues for African-American Men; Bell
Semple SJ, Shaw WS, Grant I, Jeste DV; 26(12):772- CC; 26(1):33-36.
784. Two Receptor Superfamilies Mediate Fast and Slow
Neurotransmission (Psychopharm Psnapshots);
Risperidone: A New, Novel (and _ Better?)
Stahl SM; 26(5):244-253.
Antipsychotic; Davis JM, Janicak PG; 26(2):78-87.
Schizoaffective Disorder and Psychotic Mania; Update on Treatment and Pathophysiology of Water
Hirschfeld RMA; 26(7):S435-S439. Imbalance in Schizophrenia; Goldman MB;
Schizophrenia and Substance Abuse; Frances RJ; 26(2):93-96.
26(8):523-527. Update on the Development of Medication for
Schizophrenia and the Life Course: Implications for Memory and Cognition in Alzheimer’s Disease;
Family Relations and Caregiving; Cohler BJ, Kumar V, Cantillon M; 26(5):280-284.
Beeler JA. 26(12):745-756. Use and Misuse of Psychiatry in Sexual Harassment
Schizophrenia—A New Ball Game? (Editorial); Cases, The; Malmquist CP; 26(3):149-156.
Using Cost-Effectiveness Data in Benefit Design;
Fawcett J; 26(7):384.
Second Messenger Systems (Psychopharm Goldman HH; 26(8):528-530.
Psnapshots); Stahl SM; 26(4):183-184. Valproate in the Treatment of Agitation Associated
Serotonin Pathways: Mediators of SSRI Side Effects with Depression; Schatzberg AF, DeBattista C,
(Psychopharm Psnapshots); Stahl SM; DeGolia S; 26(7):S470-S473.
26(12):738-742. Valproate in the Treatment of Behavioral Agitation
Serotonin Pathways: Mediators of SSRI of Dementia; McElroy SL, Kasckow JW, Lott AD,
Therapeutic Actions (Psychopharm Psnapshots); Keck PE Jr; 26(7):S474-S479.
Stahl SM; 26(11):695-696. We Need More Procedures—To Get More Respect
Serotonin Receptors (Psychopharm Psnapshots); (Editorial}; Fawcett J; 26(11):700.
Stahl SM; 26(8):505-507. What’s Happening to the Neuroleptic Malignant
Syndrome? (ASCP Speaks Out); Simpson GM, Pi
Sexual Harassment and Psychiatry (Editorial);
EH; 26(4):172-174.
Fawcett J; 26(3):126-127.
Stress of Caregiving for the Chronically Mentally Which Comes First? (Editorial); Fawcett J;
Ill; Vaddadi K; 26(12):766-771. 26(9):568.
Who Will Be Hospitalized After Emergency
Suicidal Behavior in Depressed Children Grown Up:
Evaluation? (Contemporary Psychiatry); Beck
Preliminary Results of a Longitudinal Study;
Wolk SI, Weissman MM; 26(6):331-335. JC, White KA, Glick RL, Baker J; 26(8):544-546.
Will Advances in the Treatment of Schizophrenia
Summary of Methods to Potentiate ECT Seizure, A;
Reach the Patient? (Editorial); Fawcett J; 26(8):515.
Swartz CM; 26(11):721.
Psychiatric Annals 26:12/December 1996